4D Molecular Therapeutics
About
Company Overview
Purpose & Strategy
Differentiation
FOUNDERS
Leadership Team
Board of Directors
CONTACT US
Technology
GENE THERAPY
Conventional Vectors
4DMT Therapeutic Vector Evolution
Product Pipeline
Pipeline Overview
Lysosomal Storage Disease
Lung disease
Muscular Dystrophy
Ophthalmological Disease
Partnerships
Industry Partners
Patient Advocacy
Patient Stories
Investors & Media
Investors
PRESS RELEASES
Working at 4DMT
Corporate Culture
Current Openings
Home
Terms of Use
Menu
News & Events
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
Read More
Liu TC, Galanis E, Kirn D.
Nature Reviews Clin Oncol (prev NCPO). 2007 Feb;4(2):101-17.